Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 281

    2.

    Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.

    Vaccaro O, Mancini FP, Ruffa G, Sabatino L, Iovine C, Masulli M, Colantuoni V, Riccardi G.

    Clin Endocrinol (Oxf). 2002 Oct;57(4):481-6.PMID: 12354130 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity.

    Stumvoll M, Wahl HG, Löblein K, Becker R, Machicao F, Jacob S, Häring H.

    Diabetes. 2001 Apr;50(4):876-81.PMID: 11289055 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.

    Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, Lewis GF, Giacca A.

    Diabetes. 1999 Mar;48(3):524-30.PMID: 10078552 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.

    Stumvoll M, Häring H.

    Diabetes. 2002 Aug;51(8):2341-7. Review.PMID: 12145143 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.

    Ylönen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C; Botnia Research Group.

    Eur J Clin Nutr. 2008 Dec;62(12):1432-9. Epub 2007 Aug 15.PMID: 17700648 [PubMed - indexed for MEDLINE]Related articles

    8.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity]

    Fritsche A, Madaus A, Tschritter O, Ozeker M, Wulle EL, Machicao F, Häring H, Stumvoll M.

    Dtsch Med Wochenschr. 2001 May 18;126(20):580-4. German. PMID: 11402923 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2.

    Thamer C, Haap M, Volk A, Maerker E, Becker R, Bachmann O, Machicao F, Häring HU, Stumvoll M.

    Horm Metab Res. 2002 Mar;34(3):132-6.PMID: 11972302 [PubMed - indexed for MEDLINE]Related articles

    11.

    Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

    Franks PW, Luan J, Browne PO, Harding AH, O'Rahilly S, Chatterjee VK, Wareham NJ.

    Metabolism. 2004 Jan;53(1):11-6.PMID: 14681835 [PubMed - indexed for MEDLINE]Related articles

    12.

    Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12Ala.

    Tschritter O, Fritsche A, Stefan N, Haap M, Thamer C, Bachmann O, Dahl D, Maerker E, Teigeler A, Machicao F, Häring H, Stumvoll M.

    Metabolism. 2003 Jun;52(6):778-83.PMID: 12800106 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents.

    Burns SF, Kelsey SF, Arslanian SA.

    Diabetes Care. 2009 Feb;32(2):355-60. Epub 2008 Nov 18.PMID: 19017772 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.

    Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS; Bogalusa Heart Study.

    Diabetes. 2003 May;52(5):1265-9.PMID: 12716762 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

    Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI.

    Diabetes. 2000 May;49(5):701-7.PMID: 10905476 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.

    Stumvoll M, Stefan N, Fritsche A, Madaus A, Tschritter O, Koch M, Machicao F, Häring H.

    J Mol Med. 2002 Jan;80(1):33-8. Epub 2001 Sep 15.PMID: 11862322 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.

    Frias JP, Basabe L, Macaraeg G, Kruszynska YT.

    Diabetes Metab. 2000 Apr;26(2):133-9.PMID: 10804328 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.

    Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF.

    Am J Physiol. 1999 Jun;276(6 Pt 1):E1055-66.PMID: 10362618 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data